[L-Dopa in Parkinson's-syndrome. New therapeutic attack?].
D000284:Administration, Oral; D001921:Brain / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D004298:Dopamine
L-Dopa bei Parkinson-Syndrom. Ein neuer therapeutischer Ansatz?